The estimated Net Worth of Vikram Karnani is at least 21.2 百万$ dollars as of 22 February 2021. Mr. Karnani owns over 8,358 units of Horizon Therapeutics Plc stock worth over 12,114,390$ and over the last 8 years he sold HZNP stock worth over 5,029,659$. In addition, he makes 4,063,290$ as Executive Vice President、 President - International at Horizon Therapeutics Plc.
Vikram has made over 9 trades of the Horizon Therapeutics Plc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 8,358 units of HZNP stock worth 728,734$ on 22 February 2021.
The largest trade he's ever made was exercising 47,337 units of Horizon Therapeutics Plc stock on 4 January 2021 worth over 5,505,293$. On average, Vikram trades about 11,194 units every 30 days since 2017. As of 22 February 2021 he still owns at least 104,165 units of Horizon Therapeutics Plc stock.
You can see the complete history of Mr. Karnani stock trades at the bottom of the page.
Vikram Karnani serves as Executive Vice President, President - International of the Company. Prior to that, he served as our senior vice president, rheumatology business unit from February 2017 to March 2018, and before that, from July 2014 until February 2017, he served as our general manager, specialty business unit. Prior to joining Horizon, Mr. Karnani was with Fresenius Kabi, a global health care company, where he served as vice president of the therapeutics and cell therapy business, from October 2011 to July 2014. Mr. Karnani also held various positions in business development, corporate strategy and strategic marketing within Fenwal Inc., a global blood technology company that was acquired by Fresenius Kabi, from November 2008 to October 2011. Mr. Karnani brings nearly 17 years of cross-functional expertise across a multitude of industries, including medical devices, management consulting, semiconductors and cellular telecommunications.
As the Executive Vice President、 President - International of Horizon Therapeutics Plc, the total compensation of Vikram Karnani at Horizon Therapeutics Plc is 4,063,290$. There are 4 executives at Horizon Therapeutics Plc getting paid more, with Timothy Walbert having the highest compensation of 13,873,200$.
Vikram Karnani is 45, he's been the Executive Vice President、 President - International of Horizon Therapeutics Plc since 2020. There are 21 older and 2 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Vikram's mailing address filed with the SEC is C/O HORIZON THERAPEUTICS PLC,, CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD, DUBLIN, L2, 4.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over 454,905,275$ worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth 58,823,653$ . The most active insiders traders include Jeff Himawan、Woodlands Health Ventures F...、Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of 12,248,018$. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth 351,691$.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: